Is someone hiding the cure for cancer? Or is the system just broken?

In this compelling episode, Dr. Dino Prato, founder of Envita Medical Centers, addresses one of the most controversial questions in cancer care: Is the cure already here—but out of reach? His answer may surprise you.

Drawing from 25+ years of clinical experience and the latest genomic science, Dr. Prato explains why the real breakthrough in cancer won’t come from a single pill—but from precision, multi-omic testing that matches treatment to your biology.

🎯 What You’ll Learn:

• Why most cancer care is based on averages, not personal biology
• How RNA, DNA, immune mapping, and spatial biology drive better outcomes
• The financial incentives behind drug approvals, high-cost treatments, and limited access
• Why off-label, natural, and targeted therapies are underused
• What precision oncology means for real-world patients — including those sent home by major hospitals
• How Envita’s model showed 35x better outcomes and 43x better quality of life in late-stage cancer cases

This episode doesn’t accuse — it educates. Because when patients are empowered with data, they stop relying on luck and start building a plan that’s personalized, intelligent, and full of hope.

“It’s not that a cure is being kept from us — it’s that the system wasn’t built to find it.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493